Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|January 8, 2026
Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet syndromeSena Fidan, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Medicine|November 12, 2015
Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome: An Observational StudyEmire Seyahi, Osman Serdal Cakmak, Burcin Tutar, et al.
Seminars in Arthritis and Rheumatism|January 29, 2008
Atherosclerosis in Behçet's SyndromeEmire Seyahi, Serdal Ugurlu, Rana Cumali, et al.
Rheumatology International|August 17, 2023
Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysisDidar Ucar, Sinem Nihal Esatoglu, Emir Cerme, et al.
Clinical and Experimental Rheumatology|October 30, 2016
Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet's syndrome patients with pulmonary artery involvement during follow-upSinem Nihal Esatoglu, Emire Seyahi, Serdal Ugurlu, et al.
Rheumatology (Oxford, England)|December 17, 2019
Long term follow-up of Behçet's syndrome patients treated with cyclophosphamideMert Gurcan, Sinem Nihal Esatoglu, Vedat Hamuryudan, et al.
Journal of Neurology|July 8, 2025
Central nervous system involvement and mimickers in ANCA associated vasculitisYeliz Yagiz Ozogul, Sinem Nihal Esatoglu, Murat Ozogul, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Rheumatology International|November 26, 2021
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndromeGuzin Ozcifci, Tahacan Aydin, Zeynep Atli, et al.
The New England Journal of Medicine|April 16, 2015
Apremilast for Behçet's syndrome--a phase 2, placebo-controlled studyGulen Hatemi, Melike Melikoglu, Recep Tunc, et al.
Pageof 5